Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
T.MAN Pharmaceutical PCLBKK:TMAN -0.88%21 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates BKK:TMAN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 444 Drug Manufacturers companies, T.MAN Pharmaceutical PCL ranks better than 57.21% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. T.MAN Pharmaceutical PCL's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for T.MAN Pharmaceutical PCL's Dividend Payout Ratio or its related term are showing as below:
BKK:TMAN'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.34 Med: 0.37 Max: 0.37
Current: 0.34
During the past 4 years, the highest Dividend Payout Ratio of T.MAN Pharmaceutical PCL was 0.37. The lowest was 0.34. And the median was 0.37.
BKK:TMAN's Dividend Payout Ratio is ranked better than 57.21% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs BKK:TMAN: 0.34
During the past 4 years, the highest Trailing Annual Dividend Yield of T.MAN Pharmaceutical PCL was 4.96%. The lowest was 1.60%. And the median was 3.78%.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
T.MAN Pharmaceutical PCL (BKK:TMAN) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
T.MAN Pharmaceutical PCL Dividend Payout Ratio Related Terms
T.MAN Pharmaceutical PCL Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for T.MAN Pharmaceutical PCL's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T.MAN Pharmaceutical PCL Dividend Payout Ratio Chart
BKK:TMAN vs ZTS, UTHR, VTRS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, T.MAN Pharmaceutical PCL's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T.MAN Pharmaceutical PCL Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, T.MAN Pharmaceutical PCL's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where T.MAN Pharmaceutical PCL's Dividend Payout Ratio falls into.
T.MAN Pharmaceutical PCL Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
T.MAN Pharmaceutical PCL's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on T.MAN Pharmaceutical PCL and its competitors. Over the past decade, T.MAN Pharmaceutical PCL's Dividend Payout Ratio has ranged from 0.34 to 0.37. According to the industry distribution chart, T.MAN Pharmaceutical PCL ranks #190 out of 444 companies in the Drug Manufacturers industry, placing it in the top 42.8%.
Is T.MAN Pharmaceutical PCL's Dividend Payout Ratio too high?
T.MAN Pharmaceutical PCL's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 0.37. Based on the distribution chart, T.MAN Pharmaceutical PCL ranks #190 out of 444 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, T.MAN Pharmaceutical PCL ranks #190 out of 444 companies for Dividend Payout Ratio. This puts T.MAN Pharmaceutical PCL in the upper half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, T.MAN Pharmaceutical PCL's own Dividend Payout Ratio has ranged from 0.34 to 0.37 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on T.MAN Pharmaceutical PCL and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. T.MAN Pharmaceutical PCL's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Dividend Payout Ratio of 0.00. The current Dividend Payout Ratio is 0.00. T.MAN Pharmaceutical PCL's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
21GF Score
Get the complete analysis for BKK:TMAN
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TMAN has been successfully added to your 
